Unipath OTC birth control system clinical trials begin June 5 at seven U.S. sites.
This article was originally published in The Gray Sheet
Executive Summary
UNIPATH OTC BIRTH CONTROL SYSTEM ENTERS CLINICAL TRIALS on June 5 in seven U.S. cities. The 1,200-couple study is evaluating use of the hormone analysis-based system to allow women to identify their entire fertile phase; Unipath Diagnostics already offers two home hormone-based fertility tests, the Clearblue Easy home pregnancy test and the Clearplan Easy home ovulation test.